Treatments:Diabetes
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
*[[NovoLog]] - Generic: [[Insulin aspart]] | *[[NovoLog]] - Generic: [[Insulin aspart]] | ||
*[[Humalog]] - Generic: [[Insulin lispro]] | *[[Humalog]] - Generic: [[Insulin lispro]] | ||
| - | =====Dipeptidyl | + | =====[[Dipeptidyl peptidase IV]] Inhibitor===== |
* [[Galvus]] - Generic: [[Vildagliptin]] | * [[Galvus]] - Generic: [[Vildagliptin]] | ||
* [[Januvia]] - Generic: [[Sitagliptin]] [[Januvia (sitagliptin)]] | * [[Januvia]] - Generic: [[Sitagliptin]] [[Januvia (sitagliptin)]] | ||
Revision as of 11:16, 10 July 2023
Insulin
Dipeptidyl peptidase IV Inhibitor
Peroxisome Proliferator-Activated Receptor Agonist
Glucagon-like peptide-1 (GLP-1) agonist
Mechanism is not completely understood
|
Proteopedia Page Contributors and Editors (what is this?)
Alexander Berchansky, David Canner, Michal Harel, Karsten Theis
